Neurolysin knockout mice generation and initial phenotype characterization by Cavalcanti, D.M.L.P. et al.
 
Repository of the Max Delbrück Center for Molecular Medicine (MDC) 
in the Helmholtz Association  
 
http://edoc.mdc-berlin.de/13981  
 
 
 
 
 
Neurolysin knockout mice generation and initial phenotype 
characterization 
 
Cavalcanti, D.M.L.P. and Castro, L.M. and Rosa Neto, J.C. and Seelaender, M. and Neves, R.X. 
and Oliveira, V. and Forti, F.L. and Iwai, L.K. and Gozzo, F.C. and Todiras, M. and Schadock, I. 
and Barros, C.C. and Bader, M. and Ferro, E.S. 
 
 
 
 
 
This is a copy of the original article. 
 
This research was originally published in Journal of Biological Chemistry. Cavalcanti, D.M.L.P. and 
Castro, L.M. and Rosa Neto, J.C. and Seelaender, M. and Neves, R.X. and Oliveira, V. and Forti, 
F.L. and Iwai, L.K. and Gozzo, F.C. and Todiras, M. and Schadock, I. and Barros, C.C. and Bader, 
M. and Ferro, E.S. Neurolysin knockout mice generation and initial phenotype characterization. J 
Biol Chem. 2014; 289: 15426-15440. © 2014 by The American Society for Biochemistry and 
Molecular Biology, Inc. 
 
 
 
Journal of Biological Chemistry 
2014 MAY 30 ; 289(22): 15426-15440 
Doi: 10.1074/jbc.M113.539148   
 
American Society for Biochemistry and Molecular Biology 
Barros, Michael Bader and Emer S. Ferro
Mihail Todiras, Ines Schadock, Carlos C.
Fábio L. Forti, Leo K. Iwai, Fabio C. Gozzo, 
Seelaender, Rodrigo X. Neves, Vitor Oliveira,
Castro, José C. Rosa Neto, Marilia 
Diogo M. L. P. Cavalcanti, Leandro M.
  
Initial Phenotype Characterization
Neurolysin Knockout Mice Generation and
Enzymology:
doi: 10.1074/jbc.M113.539148 originally published online April 9, 2014
2014, 289:15426-15440.J. Biol. Chem. 
  
 10.1074/jbc.M113.539148Access the most updated version of this article at doi: 
  
.JBC Affinity SitesFind articles, minireviews, Reflections and Classics on similar topics on the 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
Supplemental material:
  
 http://www.jbc.org/content/suppl/2014/04/09/M113.539148.DC1.html
  
 http://www.jbc.org/content/289/22/15426.full.html#ref-list-1
This article cites 84 references, 24 of which can be accessed free at
 at M
A
X
 D
ELBRU
ECK
 CEN
TRU
M
 FU
E on June 16, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 at M
A
X
 D
ELBRU
ECK
 CEN
TRU
M
 FU
E on June 16, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Neurolysin Knockout Mice Generation and Initial Phenotype
Characterization*□S
Received for publication,November 29, 2013, and in revised form, April 7, 2014 Published, JBC Papers in Press, April 9, 2014, DOI 10.1074/jbc.M113.539148
DiogoM. L. P. Cavalcanti‡1,2, Leandro M. Castro§¶1,3, José C. Rosa Neto‡, Marilia Seelaender‡, Rodrigo X. Neves‡,
Vitor Oliveira¶3, Fábio L. Forti, Leo K. Iwai**, Fabio C. Gozzo‡‡, Mihail Todiras§§, Ines Schadock§§,
Carlos C. Barros§§¶¶, Michael Bader§§, and Emer S. Ferro§3,4
From the Departments of ‡Cell Biology and Development and §Pharmacology, Support Center for Research in Proteolysis and Cell
Signaling, Biomedical Sciences Institute, University of São Paulo, São Paulo, SP 05508-900, Brazil, the ¶Department of Biophysics,
Federal University of São Paulo, São Paulo, SP 04039-032, Brazil, the Department of Biochemistry, Support Center for Research in
Proteolysis and Cell Signaling, Institute of Chemistry, University of São Paulo, São Paulo, SP 05508-000, Brazil, the **Special
Laboratory of Applied Toxinology, Center of Toxins, Immune Response and Cell Signaling, Butantan Institute, São Paulo, SP 05503-
000, Brazil, the ‡‡Institute of Chemistry, State University of Campinas, Campinas, SP 13083-862, Brazil, the §§Max-Delbrück-Center
for Molecular Medicine, D-13125, Berlin, Germany, and the ¶¶Department of Nutrition, Federal University of Pelotas,
Pelotas, RS 96010-610, Brazil
Background: Neurolysin is known to cleave several bioactive peptides in vitro.
Results:Neurolysin knock-out mice showed increased glucose tolerance, insulin sensitivity, and gluconeogenesis, which likely
relates to increased expression of both specific liver mRNAs and intracellular peptides.
Conclusion: Neurolysin plays a role in energy metabolism.
Significance: Neurolysin could be used as a therapeutic target to counteract insulin resistance.
The oligopeptidase neurolysin (EC 3.4.24.16; Nln) was first
identified in rat brain synaptic membranes and shown to ubiq-
uitously participate in the catabolism of bioactive peptides such
as neurotensin and bradykinin. Recently, it was suggested that
Nln reduction could improve insulin sensitivity. Here, we have
shown thatNlnKOmice have increased glucose tolerance, insu-
lin sensitivity, and gluconeogenesis. KO mice have increased
liver mRNA for several genes related to gluconeogenesis. Iso-
topic label semiquantitative peptidomic analysis suggests an
increase in specific intracellular peptides in gastrocnemius and
epididymal adipose tissue, which likely is involved with the
increased glucose tolerance and insulin sensitivity in the KO
mice. These results suggest the exciting new possibility that
Nln is a key enzyme for energy metabolism and could be a
novel therapeutic target to improve glucose uptake and insulin
sensitivity.
Neurolysin (EC 3.4.24.16; Nln)5 is a zinc metalloendopepti-
dase with a conserved HEXXHmotif. Nln was first identified in
synaptic membranes of the rat brain by the specific cleavage
and inactivation of the peptide neurotensin at the Pro-Tyr bond
(1–3). Nln is a monomeric protein with a molecular mass of 78
kDa and 704 amino acid residues that hydrolyzes only peptides
containing 5–17 amino acids by cleaving at a limited set of sites
that are nonetheless diverse in sequence (4–9). The specificity
of Nln for small bioactive peptide substrates without bulky sec-
ondary and tertiary structures is due to the presence of large
structural elements erected over its active site region that allow
substrate access only through a deep narrow channel (10). It is
well established by biochemical analyses in vitro that Nln
cleaves a number of bioactive peptides including neurotensin,
bradykinin, hemopressin, and several opioid peptides at se-
quences that vary widely (5, 10, 11).
Nln is widely distributed in mammalian tissues and is found
in different subcellular locations that vary with cell type (12–
14). Much of the enzyme is cytosolic, but it also can be secreted
or associated with the plasma membrane (12, 14), and some of
the enzyme is synthesized with a mitochondrial targeting
sequence by initiation at an alternative transcription start site
(5, 15). Light and electron microscopic immunohistochemical
studies have indicated that within the brain, Nln is present in
both neurons and glia (12–14, 16). Studies in the neuroendo-
crine cell line AtT-20 have shown that Nln is enriched in the
regulated secretory pathway (17). Nln was also shown to be
released from glial cells in culture (14). The mechanism under-
lying Nln release is unclear, however, because the enzyme has
no signal peptide or a hydrophobic membrane-spanning
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domain (14, 18). In vivoNlnhas been suggested to be implicated
in pain control (19–21), blood pressure regulation (22, 23), sep-
sis (24), reproduction (25, 26), cancer biology (27), and patho-
genesis of stroke (28).
Previous studies suggested the involvement of proteases,
peptidases, and peptides in metabolic disorders such as insulin
resistance, obesity, and metabolic syndrome (29–32). For
instance, carboxypeptidase E knock-out mice (Cpefat/fat) show
an obesity phenotype (33, 34), and dipeptidyl peptidase 4-defi-
cient mice are resistant to developing adiposity and obesity
induced by high fat diet and exhibit improved insulin sensitivity
(29, 30). Nln activity is significantly lower in the fat tissue of
transgenicmice that are possessed three copies of the angioten-
sin-converting enzyme (ACE) gene. When these mice were fed
a high fat diet, they showed better preserved insulin sensitivity
compared with the group containing a single copy of the ACE
gene (35). The reducedNln activity in animals containing three
copies of the ACE gene seem to correlate with a distinctive
intracellular peptide profile of these animals; these results sug-
gested that intracellular peptides could improve insulin sensi-
tivity in the adipose tissue (35). Moreover, additional peptido-
mic studies using semiquantitative LC-MS/MS have shown
that the intracellular levels of two of ten intracellular peptides
found in the epididymal adipose tissue of animals, were at least
two times higher in rats fed with a hypercaloric diet when com-
pared with a control group. Indeed, if added back into 3T3-L1
adipocytes, these intracellular peptides significantly increased
glucose uptake, corroborating the suggestion that intracellular
peptides may be functional and regulate insulin signal trans-
duction and glucose uptake in the adipose tissue (35, 36).
Here, Nln KO mice were generated to allow further investi-
gation on the biological function of this peptidase in energy
metabolism. Our initial phenotype characterization of KO
mice seem to corroborate previous suggestions that Nln plays a
physiological role in energetic balance increasing glucose toler-
ance, insulin sensitivity, and liver gluconeogenesis. However,
although one cannot exclude compensatory mechanisms for a
subset of Nln-associated phenotypes, we did not observe a key
role of this oligopeptidase in blood pressure regulation.
EXPERIMENTAL PROCEDURES
Generation of Nln Knock-out Mice—The Nln gene trap
knock-out mouse strain was generated by C57BL/6 blastocyst
microinjection of genetically modified embryonic stem cells
(NPX481, 129ola) obtained from Baygenomics through the
International GeneTrapConsortium. The geneticallymodified
Nln allele of the NPX481 strain has the gene trap vector
pGT1dTMpfs inserted between exon 1 and exon 2 (Fig. 1A), as
evidenced by sequencing 5-rapid amplification of cDNA ends
cDNA from the original NPX481 embryonic stem cell line
(CC178547) used to generate this mice strain (a detailed report
about this embryonic stem cell line can be found at the Inter-
national Gene Trap Consortium website).
After transmission of the knock-out allele from chimera to
F1 generation, Nln mice were obtained from heterozygous
breeding, and the line was further maintained on the mixed
FIGURE 1.Generation of Nln knock-outmice. A, representation of Nln gene structure and the location of the NPX481 line gene trap insertion. The position of
the Nln locus on a schematic representation of the mouse chromosome 13 is shown as a red vertical line (chr13-qD1). The Nln exons are represented as blocks
connected by arrowed lines, where blue blocks indicate the coding, and black blocks indicate the untranslated regions. B, PCR for genotyping of Nln knock-out
animals. C, qPCR showing absence of gene expression in KO animals in different tissues. D, Western blot showing Nln protein expression (arrow) in different
organs (kidney, liver, and brain) in WT and KO. E, enzyme activity confirming the results of the genotyping and qPCR. HET, heterozygous; Kid, kidney; Liv, liver;
Bra, brain; ND, not detected.
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background by breeding Nln/ with Nln/ animals. To
obtain such mice on a pure genetic background, we bred F1
(129/OlaHsd/C57BL/6 background) heterozygous Nln-defi-
cient animals to the inbred C57BL/6 mouse line (Charles
River) for 10 generations before using them for experimental
investigations.
The mice were maintained in individual ventilated cages
(Tecniplast Deutschland) under standardized conditions with
an artificial 12-h dark-light cycle, with free access to standard
chow (Ssniff) and drinking water ad libitum. The experiments
were performed with adult mice (24 weeks old). This study was
approved by the Ethics Committee of Institute of Biomedical
Sciences at the University of São Paulo (protocol register num-
ber 44, page 86).
Genotyping—Genotypingof animalswasperformedusingPCR
with primer NlnF3 (5-CGCCTCCTGCACCTACCA), pNlnwtR3
(5-ATTTGCCAGGTTAAGAGATCG), and pNlnkoR2 (5-
CGTGTCCTACAACACACACTCC). The absence of Nln
transcripts in the liver, muscle, and adipose tissue of Nln-defi-
cient animals was confirmed by qPCR with the primer pair
Nln-Fw (5-CTGAAGGCCTGCTAAGCATC-3) and Nln-Rv
(5-CGCATGGTTGTATTTTCCT-3).
Enzymatic Activity—The enzymatic activity of Nln was de-
termined in triplicate using a continuous assaywith a quenched
fluorescent substrate (7-methoxycoumarin-4-acetyl-P-L-G-P-
dK-(2,4-dinitrophenyl) as previously described (5). The Nln
specific inhibitor Pro-Ile (5 mM) (37) was used to discern the
peptidolytic activity attributed exclusively to Nln. The results
were expressed as arbitrary units of fluorescence per minute
normalized by protein concentration.
Body Composition—Body composition (free water, fat, and
lean mass) was estimated in 6-month-old mice by dual energy
x-ray absorptiometry using a Hologic QDR 4500 scanner
(Hologic, Waltham, MA) as described previously (38).
GTT, ITT, and Gluconeogenesis—Mice were fasted for 12 h,
and blood samples were taken before and 15, 30, 60, 90, and 120
min after the injection of 2 g/kg glucose (GTT) or 0.75 unit/kg
insulin (ITT). Gluconeogenesis was assessed by injecting 2 g/kg
sodium pyruvate after 16 hof fasting. In all three assays, glyce-
mia was measured using a glucometer (Accu-Check Performa;
Roche).
Western Blot—For determining insulin signaling in vivo, we
collected samples of muscle, liver, and epididymal adipose tis-
sue before and 5 min after tail vein injection of insulin (5 units/
kg) as previously described (39). The samples were immediately
stored in liquid nitrogen.
For Western blot analyses, tissue lysates were homogenized
in radioimmune precipitation assay buffer containing inhibi-
tors of proteases (Complete; Roche) and phosphatases (Phos-
STOP; Roche). Samples were subjected to SDS-PAGE in a Bio-
Rad electrophoresis apparatus (Mini-Protean). Proteins were
transferred to a PVDF membrane (Thermo Scientific Pierce).
After 2 h in blocking buffer (Odyssey; LI-CORBiosciences), the
membranes were incubated with anti-Nln (rabbit polyclonal
antibody; Abcam), anti-phospho-AKT (Ser-473), or anti-AKT
(rabbit polyclonal antibody; Cell Signaling) overnight at 4 °C
and then incubated with IRDye secondary antibody (Odyssey;
LI-CORBiosciences). The results were visualized in anOdyssey
infrared imaging system (Odyssey; LI-COR Biosciences) and
was quantified by densitometry with Odyssey infrared imaging
software (Odyssey; LI-COR Biosciences).
Histological Analysis—Weperformedhematoxylin and eosin
staining for histological analysis in gastrocnemius, soleus, liver,
and adipose tissue. For mitochondrial activity, we used a tetra-
zolium compound and 3,3-diaminobenzidine to identified
sites for succinate dehydrogenase (SDH) and cytochrome oxi-
dase (COX), respectively, in fresh frozen sections of gastrocne-
mius, as previously described (40, 41). All data acquisition and
analysis were performed in a microscopy BZ-9000 (BIOREVE).
Real Time PCR—We used real time qPCR to determine
mRNA expression in liver, muscle, and adipose tissue. Animals
fasted for 12 h were sacrificed by decapitation, and tissues were
removed, snap frozen in liquid nitrogen, and stored in 80 °C
until use. Samples were homogenized, and total RNA was iso-
lated using TRIzol protocol (TRIzol products; Invitrogen).
The total RNA was cleaned in a RNeasy mini kit (Qiagen), and
the RNA integrity was assessed by electrophoresis on 1% aga-
rose gels.
cDNAwas synthesized from1g of total RNAwithMoloney
murine leukemia virus reverse transcriptase (Invitrogen) using
random hexamer nucleotides. Standard curves for all primers
were made to determine the amplification efficiencies of target
and reference genes. Quantitative PCR was performed on an
ABI Prism 7900 (Applied Biosystems) sequence detection sys-
tem with 100 nM primers and 20 ng of cDNA. Target mRNA
expression was normalized to GAPDH expression and
expressed as a relative value using the comparative threshold
cycle (Ct) method (2Ct) according to the manufacturer’s
instructions. Expression levels from genes of interest were nor-
malized to WT control mice and presented as fold change. All
primers sequences used herein are described in supplemental
Table S1.
Graded Treadmill Exercise Test—Exercise capacity, esti-
mated by total distance run, correlates with skeletal muscle
work capacity. Exercise capacity was evaluated with a graded
treadmill using protocols from previously published reports.
Briefly, after being adapted to treadmill exercises over a week
(10 min of exercise per session); mice were placed in the tread-
mill streak and allowed to acclimatize for at least 30 min. We
used high and low intensity running regimens. For high inten-
sity running, intensity of exercise was increased by 3 m/min
every 3 min until exhaustion. Exhaustion was defined as the
time when animals were unable to keep pace with the treadmill
for up to 1 min. For low intensity running, we used the average
speed in the high intensity running and calculated 70% of this
result (21m/min) and put all animals to run in this constant
speed until exhaustion for maximum capacity of physical
exercise.
Blood Pressure—Measurement of blood pressure was per-
formed as previously described (42). KO andWTwere anesthe-
tized with isoflurane and then a modified catheter (type MRE:
0.25-inch outer diameter and 0.012-inch inner diameter; Brain-
tree Scientific, Braintree, MA) was placed into the abdominal
aorta via the femoral artery for measurement of arterial blood
pressure. The blood pressure was measured using a transducer
(MLT 1050 model) connected to a computer system for data
Neurolysin KOMice
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analysis (PowerLab; AD Instruments, Colorado Springs, PA)
(43). To test blood pressure response to different drugs (1 nM
neurotensin, 5 and 10 mg/kg bradykinin, and 100 ng/kg angio-
tensin II), a secondmodified catheter was placed in the femoral
vein.
Peptide Extraction—Peptide extracts were prepared as previ-
ously described (44, 45). Briefly, 6-month-oldmicemale (n 5)
were sacrificed by decapitation, and gastrocnemius, soleus,
liver and epididimal adipose tissuewere collected and subjected
to 10 s of microwave (1500 watts; Electrolux) radiation to inac-
tivate protein and peptide degradation. Each sample was
homogenized (Polytron; Brinkmann) in 10 ml of water and
incubated at 80 °C for 20 min. After cooling on ice, 20 l of 5 M
HCl was added to give a final concentration of 10 mM and son-
icated three timeswith 20 pulses (4Hz). The homogenateswere
centrifuged at 1,500 g for 40 min at 4 °C. After this point, the
supernatants were collected and centrifuged at 15,000  g for
40 min at 4 °C. The resulting supernatants were collected and
filtered through a Millipore membrane (molecular weight cut-
off  10,000; Amicon UltraTM; Millipore). The flow-through
was applied to C18-like Oasis columns (Waters) (Fig. 2). The
peptide extracts were resuspended in 100l of deionized water
and kept at80 °C.
Peptide Quantification—Peptide concentration was deter-
mined as previously described (44, 46). The reaction was per-
formed at pH 6.8 to ensure that only the amino groups of pep-
tides and not those of free amino acids react with fluorescamine
(47). Briefly, 2.5l of each sample wasmixedwith 25l of 0.2 M
phosphate buffer (pH 6.8) and 12.5 l of a 0.3 mg/ml fluores-
camine solution in acetone. After vortexing for 1 min, 110 l
of water was added, and fluorescence was measured with a
SpectraMaxM2e plate reader (Molecular Devices) at an excita-
tion wavelength of 370 nm and an emission wavelength of 480
nm. The peptide 5A (LTLRTKL), of known composition and
concentration, was used as the standard reference for deter-
mining the peptide concentration.
Isotopic Labeling—The isotopic labeling of peptides for
semiquantitation was performed as originally described (48,
49). Fifty micrograms of peptide extract from gastrocnemius,
soleus, liver, or epididymal adipose tissue were combined with
200 l of 0.4 M phosphate buffer, pH 9.5. The pH was adjusted
to 9.5with 1MNaOH, 6.4l of a solution 350g/l D0-TMAB,
D3-TMAB, orD9-TMAB, dissolved inMe2SOwas added.After
10 min at room temperature, an appropriate volume of 1.0 M
NaOHwas added to the reactionmixture to adjust the pH back
to 9.5, and the reaction was further incubated for 10 min. The
FIGURE 2. Scheme for intracellular peptide extraction, labeling, and LC-MS/MS analysis. First, the scheme shows briefly step by step the protocol for
intracellular peptide extraction. For isotopic labeling with TMAB, we used three isotopic tags for each replicate. Intracellular peptides extracted from adipose
tissue, gastrocnemius, liver, and soleus were labeled with D0-TMAB, D3-TMAB, and D9-TMAB and pooled as indicated in three different runs. The runs were
labeledwith reverse isotopic tags as control of the reactivity. The relativequantification is performedbymeasuring the intensity of thepeakof peptide labeling
with each isotopic tag fromMS, taking an average of these values, and comparing the ratio of KO to theWT. For peptide identification, theMS/MS spectrawere
analyzed with a Mascot program to identify the sequences followed by manual interpretation to eliminate false positives.
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addition of labeling reagent and alkaline solution was repeated
six times over 2 h, and the mixture was incubated at room
temperature for 30min. After incubation, 30l of 2.5 M glycine
was added to the reaction to quench any remaining labeling
reagent. After 40 min at room temperature, the hydrogen and
deuterium samples were combined and centrifuged at 800 g
for 5min at 4 °C. The pHwas adjusted to 9.0–9.5, and 3l of 2.0
M hydroxylamine was added to remove TMAB labels from Tyr
residues. The addition of hydroxylamine was repeated twice
more over 30 min. The samples were desalted with a C18 col-
umn (Oasis Millipore, Billerica, MA). The peptides were
applied to C18-like Oasis columns (Waters), eluted with 100%
methanol, 015% trifluoroacetic acid, and dried in a vacuumcen-
trifuge. Samples were resuspended in 10 l of deionized water
(Fig. 2).
Mass Spectrometry andMSandMS/MSDataAnalyses—LC-
MS/MS experiments were performed on a Synapt G2 QTOF
mass spectrometer (Waters) as described previously (44). To
identify peptides, the raw data files were converted to a peak list
format (mgf) byMascot Distiller version 2.1.1 (Matrix Science)
and analyzed using the search engine MASCOT version 2.2
(Matrix Science). The SwissProt database was used for searches
with taxonomyMusmusculus, ’’no enzyme,” and 0.2Da ofmass
tolerance for MS and MS/MS precursor ions. Mascot searches
were followed by manual interpretation to eliminate false pos-
itives. Quantification was performed by measuring the ratio of
peak intensity for the various TMAB-labeled peptide pairs in
the MS spectra. For this analysis, the monoisotopic peak and
the peaks containing one or two atoms of 13C were used.
Multiple scans of theMS spectra were combined prior to quan-
titation (Fig. 2).
Gene Ontology Analysis—The 40 proteins obtained from the
peptidomic analyses shown in supplemental Table S3 plus Nln
(shown in supplemental Table S4) were subjected to Gene
Ontology (GO) clustering analysis using Biological Network
GeneOntology (BiNGO) software (50), a freely available plugin
for the Cytoscape software, version 3.0.1 (51). The selected
ontology file was based on Biological Process, the annotation
file was based on Homo sapiens databanks, and the selected
categories to be visualized discarded the evidence codes by
overrepresentation after correction. The degree of functional
enrichment for that list of proteins was obtained quantitatively
(p value) with the hypergeometric distribution statistical test
(52, 53), whichworked independently inside of theBiNGOsoft-
ware application platform, and the corrected p value was
obtained after applying false discovery rate control (85) correc-
tion with a significance level of 0.05. The selected reference test
was the whole annotation from databases.
Construction of Physical Protein-Protein Interaction (PPPI)
Networks—To design and construct a potential PPPI network
containing Nln and the proteins represented by peptides from
the peptidomic analyses shown in supplemental Table S3, we
initiated data mining of human protein-protein interaction
databases using them as a seed list. This procedure was carried
out inside the Cytoscape platform with the APID2NET Cyto-
scape Plug-in software (54). The obtained network was named
Union (because it was originated by the union of proteins iden-
tified in the gastrocnemius, liver, soleus, and adipose tissue
samples), which was then submitted to GO analysis again, as
above described.
Statistics—The values are expressed as means  S.E. Statis-
tical analyses were conducted by Student’s unpaired t test for
independent samples or ANOVA followed by Bonferroni’s test
to compare more than two groups. p values 	 0.05 were con-
sidered significant.
RESULTS
Gene Trap Strategy for Knock-out of Nln Expression in
Mice—The summarized strategy of generating Nln KOmice by
insertion of a gene trap between exons 1 and 2 is illustrated in
Fig. 1A. The presence of the gene trap in the Nln gene of the
knock-out mice was confirmed by genotyping (Fig. 1B). To
obtain a pure genetic background, we bred F1 heterozygous
Nln-deficient animals to the C57BL/6 mouse line for 10 con-
secutive generations.After 10 generations, theNlnmRNA, pro-
tein levels and enzymatic activity were investigated in various
tissues, confirming the absence of Nln mRNA and protein
expression in these KO mice (Fig. 1, C–E).
Initial Phenotypical Characterization of Nln Knock-out
Mice—Disruption of Nln expression caused neither embryonic
lethality nor changes in the normal Mendelian distribution fol-
lowing intercrossing of the heterozygotes. KO mice could not
be visually distinguished from WT C57BL/6 littermates and
had normal external appearance and fertility. KO andWTmice
also showed similar muscle mass, free water, and fat mass com-
position as analyzed by densitometry (Fig. 3, A–C). In contrast,
KO mice showed a slight although statistically significant (p	
0.05) 
10% decrease in body weight compared with WT (Fig.
3D); however, no difference in the specific mass of the internal
organs was observed (supplemental Table S2). There was also
no obvious difference in the morphology of skeletal muscle,
liver, and epididymal adipose tissue stained with hematoxylin
and eosin1 (Fig. 3, E–J).
Insulin Sensitivity andGluconeogenesis Tests—The basal glu-
cose levels of WT and KO are similar (Fig. 4A). However, the
intraperitoneal GTT done inWT and KO fasted for 12 h shows
lower glucose concentrations at 15, 30, 60, and 90 min in KO
compared with WT (Fig. 4, B and C). To further assess insulin
sensitivity, we performed the ITT in 12-h-fasted mice. Con-
sidering the normalized curve for the ITT data (Fig. 4D) and
the constant rate for glucose disappearance (KITT; Fig. 4E),
KO showed an increase of insulin sensitivity when compared
withWT. The liver gluconeogenesis capacity of KO is higher
compared withWT animals (Fig. 5,A and B), as shown by the
intraperitoneal pyruvate tolerance test in animals fasted for
16 h.
Comparative analyses of several regulatory genes involved in
liver gluconeogenesis were performed in WT and KO using
qPCR. These results suggest that KO have increased liver
mRNA for the Fbp1 (fructose bisphosphatase 1), PPAR (per-
oxisome proliferator-activated receptor ), and Creb1 (cAMP-
responsive element-binding protein 1), and Cox4i1, which is in
agreement with an increased liver gluconeogenesis of KOwhen
compared with the WT animals (Fig. 5C).
Graded Treadmill Exercise Tests—WT and KO mice per-
formance on a treadmill was evaluated in two different tests.
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First, animals were subjected to a high intensity running regime
that increased the speed stepwise every 3 min up to the ratio of
3 m/min until exhaustion. These results showed no statistical
difference between WT and KO animals (Fig. 6, A and B); on
average, WT and KO mice ran 422 and 337 m, respectively,
before complete exhaustion. Second, animals were subjected to
a low intensity running regime (21 m/min constant) until
exhaustion, and the KO (637 m) ran significantly (
36%) less
when compared withWT (997 m) (Fig. 6, C and D), suggesting
that Nln is linked to oxidative metabolic capacity and physical
exercise endurance.
Molecular Basis of Increased Glucose Metabolism in KO
Mice—To further investigate the molecular basis correlated
with the higher insulin responsiveness in KO, we analyzed the
insulin signal transduction pathway through AKTSer-473 phos-
phorylation in the gastrocnemius, liver, and epididymal adipose
tissues of bothWT andKO animals.Whereas the basal levels of
AKTSer-473 phosphorylation were similar betweenWT and KO
animals (Fig. 7, A–C), following a stimulus with an acute intra-
venous insulin injection, it was higher in gastrocnemius (Fig.
7A) and epididymal adipose tissue (Fig. 7B) but not in the liver
(Fig. 7C) of KO compared with WT animals.
FIGURE 3.Bodyweight, basal glucose levels, andbody composition.A–C, body composition ofmusclemass (A), freewater (B), and fat (C) (n 6).D, average
bodyweight ofWT and24-week-old KOanimals (n 6). The data are presented asmeans S.E. Student’s unpaired t testwas used. *, p	 0.05.A–J, histological
analysis. E and F, muscle histological sections (gastrocnemius) stained with hematoxylin and eosin of 24-week-old WT and KO animals, respectively. G and H,
liver histological sections stained with hematoxylin and eosin of 24-week-old WT and KO animals, respectively. I and J, epididymal adipose tissue histological
sections stained with hematoxylin and eosin of 24-week-old WT and KO animals, respectively (n 5).
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Fast Twitch Type II Fibers Remodeling inNln Knock-outMice
in Gastrocnemius—The enzymatic activity of Nln in WT gas-
trocnemius (predominantly fast twitch type II fibers) is approx-
imately three times lower than in the soleus (predominantly
slow twitch type I fibers), liver, or epididymal adipose tissues
(Fig. 8). Based on this finding and because KO mice ran less
thanWTmice in the low intensity running regimeuntil exhaus-
tion, we decided to investigate a possible remodeling of fiber
compositions in skeletal muscle. Using qPCR, we analyzed
mRNA expression of specific genes for slow twitch type I
(Tnni1, Tnnt1, Tnnc1, and Myh7) and fast twitch type II fibers
(Tnni2, Pvalb, Myh1, Myh2, and Myh4) in gastrocnemius and
soleus (Fig. 9, A and B). KO showed a decrease in mRNA
expression typical for slow twitch type I fibers in gastrocnemius
FIGURE 4.Glucose and insulin tolerance test.A, basal blood glucose levels after fasting for 12 h (n 6). B, GTT after fasting for 12 h of 24-week-oldWT and KO
animals (n 6). C, area under the curve (AUC) for the glucose tolerance test. D, after fasting for 12 h of 24-week-old WT and KO animals (n 6). E, calculation
of the constant of glucose disappearance (KITT) for the insulin tolerance test. The data are presented as means  S.E. Student’s unpaired t test or ANOVA
followed by Bonferroni’s test was used. *, p	 0.05; **, p	 0.01; ***, p	 0.001.
FIGURE 5. Pyruvate tolerance test and hepatic gluconeogenesis regulatory enzymes. A, pyruvate tolerance test of 24-week-old WT and KO animals to
check the level of gluconeogenesis in the liver (n 6). B, area under the curve for the pyruvate tolerance test. C, quantitative real time PCR for genes that are
related to gluconeogenesis in the liver (n 6). The data are presented as means S.E. Student’s unpaired t test or ANOVA followed by Bonferroni’s test was
used. *, p	 0.05; **, p	 0.01; ***, p	 0.001. AUC, area under the curve.
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but not in soleus, whereas no differences were observed for fast
twitch type II fibers in both skeletal muscles (Fig. 9, A and B).
Next, histological sections of gastrocnemius were stained for
the mitochondrial enzymes SDH (Fig. 10, A and B) and COX
(Fig. 10, D and E). Indeed, KO showed a significant decrease in
the number of oxidative fibers (slow twitch type I) stained for
both SDH (Fig. 10C) and COX (Fig. 10F) in the gastrocnemius
tissue.
Distinctive Intracellular Peptide Profile of KO and WT in
Skeletal Muscle, Liver, and Adipose Tissue—Semiquantitative
peptidomic analyses using isotopic labeling and LC-ESI-MS
were performed to identified possible differences in the global
peptide profile between WT and KO animals (supplemental
Table S3). Altogether, 736 MS peptide spectra were quantified
including those peptides that were not sequenced by MS/MS
(supplemental Table S3). All of these peptides were fragments
of intracellular proteins, of which the relative levels seemed
slightly affected by the lack of Nln. In accordance to previous
reports (36, 44, 49), we postulated that Nln should be a key
enzyme to metabolize peptides that have increased or
decreased 2-fold (more than 100%of increase ormore than 50%
of decrease) in KO compared with WT mice; peptides that
increase are considered potential Nln substrates, whereas pep-
tides that decreased are considered potential Nln products.
Thus, from the total of peptides identified (supplemental Table
S3), only a small number could be considered either substrates
or products ofNln (Table 1). In the gastrocnemius two peptides
derived from troponin I, fast skeletal muscle, SADAML-
KALLGSKHK and DMEVKVQKSSKELEDMNQKL, increased
more than 2-fold (supplemental Table S1B). In the adipose tis-
sue two different peptides, one derived from the acyl-CoA-
binding protein (VEKVDELKKKYGI) and one derived from the
hemoglobin subunit  (LASVSTVLTSKYR), increased more
than 2-fold (supplemental Table S3A). In the liver, several
endocannabinoid peptides containing the mouse hemopressin
(PVNFKLLSH) endocannabinoid signature (SDLHAHKLR-
VDPVNFK, RVDPVNFKLLS,VDPVNFKLL,VDPVNFKLLSH,
and RVDPVNF), or the previously identified antinociceptive
AGH peptide (AGHLDDLPGALSA) decreased more than
2-fold (supplemental Table S3C). In the soleus, only the peptide
FASFPTTK derived from the hemoglobin  subunit decreased
more than 2-fold (supplemental Table S3D). None of the pep-
tides identified in the gastrocnemius or in the epididymal adi-
pose tissue decreased more than 2-fold. In liver and soleus tis-
sues, none of the identified peptides increased more than
2-fold. Moreover, all the peptides identified here to change the
relative concentration among KO and WT were in the size
range of Nln substrate specificity, which are peptides contain-
ing
5–20 amino acids. These data suggest a great specificity of
Nln for metabolizing intracellular peptides and/or a compen-
satory mechanism occurring in the KO mice.
Nln Knock-out Mice Did Not Show Any Difference in Blood
Pressure Parameters—A possible key role of Nln in degrading
circulating bioactive peptides was first investigated through
blood pressure monitoring, introducing a catheter in the fem-
oral artery as previously described (42). Under basal conditions,
WT and KO have similar mean arterial pressure (109.0  1.5
versus 108.0 1.5mmHg, respectively; Fig. 11A) and heart rate
(668.4 8.8 versus 652.0 14.5 beats permin, respectively; Fig.
11B). Next, we challenged the participation of Nln in blood
pressure regulation injecting vasoactive peptides such as brady-
kinin, neurotensin, and angiotensin II in two different doses (5
and 10mg/kg).However, no significant differenceswere seen in
the blood pressure effects of these peptides comparing WT to
FIGURE 6. Resistance and endurance running test. A, running performance with high intensity individual and group average of 24-week-old WT and KO
animals (n 7). B, running time average of the high intensity test. C, running performancewith low intensity individual and group average of 24-week-oldWT
andKOanimals (n7).D, running timeaverageof the low intensity test. Thedata arepresentedasmeansS.E. Student’s unpaired t testwasused. **.p	0.01.
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KO responses (Fig. 11, C–E). These data suggest that Nln alone
is not a key enzyme in blood pressure regulation.
Gene Ontology Analysis and PPPI Networks—The intracellu-
lar peptides identified by LC-ESI-MS in the four peripheral tis-
sues (adipose tissue, gastrocnemius, liver, and soleus) and
shown in supplemental Table S3 were used to generate a list of
thirty-nine proteins, which together with Nln itself were used
for further in silico analysis (supplemental Table S4). To dis-
cover biological processes affected by the ablation of Nln, these
proteins were submitted to GO analyses (Table 2), considering
significant results only when the p value was below 105. The
list of biological process and genes related to these peptides are
shown in Table 2. Most of the genes identified in the GO anal-
yses are involved in basal energetic metabolism, such as glycol-
ysis and glucose metabolism (ALDOA, G3PT, PGAM2, and
CPSM) and muscle contraction (ALDOA, PGAM1, PGAM2,
SMPX, andMYL1). qPCR analyses were performed to evaluate
the effect of Nln KO in the expression of several of these genes,
in the gastrocnemius and soleus (Fig. 12). These data suggest
that Nln KO enhances CPSM and reduces PGAM1 and
PGAM2 gene expression in the gastrocnemius, which is not
observed in the soleus (Fig. 12).
Moreover, to identify other biological processes inwhichNln
might act as a direct or indirect regulator, we started data min-
ing in physical protein-protein interaction databases by using
as input the 40 proteins from supplemental Table S4 and con-
structed a network named Union (supplemental Fig. S1),
because of the union of nonoverlapping proteins found in
the gastrocnemius, liver, soleus, and adipose tissue samples,
together with Nln. Despite the fact that a few proteins were not
found in the human PPPI databases (used here because it is
more complete and updated than the mouse database), the
resulting network presented 229 proteins (nodes) and 680 con-
nections, between the 40 input proteins and other related ones
acting as substrates or interacting partners. In this complex
network, Nln is initially not part of the biggest network (sup-
plemental Fig. S1). However, as suggested by our results, Nln
can interfere with other proteins, pathways, and biological pro-
cesses. Thus, the obtained Union network was submitted to a
new GO analysis, for enlarging the list of genes and biological
processes that could be affected by the knock-out of Nln
(supplemental Table S5). In addition to the general and tissue-
FIGURE 7. AKT glucose signaling analysis by Western blotting. A–C,
Western blot showing AKT phosphorylation without () and with ()
insulin stimulation normalized to GAPDH in 24-week-old WT and KO ani-
mals (n  6). A, muscle; B, adipose tissue; C, liver. Levels of AKT phospho-
rylation in each tissue are represented by the ratios of phosphorylated
(pAKT) (Ser-473) to total (t-AKT). The data are presented as means  S.E.
ANOVA followed by Bonferroni’s test was used. *, p	 0.05; **, p	 0.01; ***,
p 	 0.001.
FIGURE 8. Nln enzymatic activity in skeletal muscle, adipose tissue, and
liver. Shownare the levels of soleus (predominantly slow twitch type I fibers),
gastrocnemius (predominantly fast twitch type II fibers), liver, andepididymal
adipose tissue of C57BL/6 (n  3). The data are presented as means  S.E.
ANOVA followed by Bonferroni’s test was used. *, p	 0.05; **, p	 0.01; ***,
p	 0.001. UAF, arbitrary units of fluorescence.
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specific biological processes already found in Table 2, other
biological processes related to the nervous system were also
identified, such as: (a) regulation of nerve impulse transmission
through synapses; (b) nervous systemdevelopment; (c) learning
and memory; (d) regulation of synaptic plasticity; (e) cell mor-
phogenesis involving neuron differentiation; (f) response to dif-
ferent types of stressor agents; (g) DNA damage and repair
pathways; (h) regulation of cell proliferation (S and M phases);
FIGURE9.Real timePCRanalysis of type I/II specific geneandmyosinheavy chaingeneexpression indifferent skeletalmuscle.A, quantitative real time
PCR for specific genes from slow twitch type I fibers and fast twitch type II fibers in gastrocnemius (n 6). B, quantitative real time PCR for specific genes from
slow twitch type I fibers and fast twitch type II fibers in soleus (n 6). The data are presented as means S.E. Student’s unpaired t test was used. **, p	 0.01;
***, p	 0.001.
FIGURE 10.Mitochondrial enzymatic activity in gastrocnemius. A and B, muscle histological sections showing the SDH staining of 24-week-oldWT and KO
animals, respectively. C, relative quantification of histochemical succinate dehydrogenase staining (n 4).D and E, muscle histological sections showing COX
staining of 24-week-oldWT and KOmice, respectively. F, relative quantification of histochemical cytochrome oxidase (n 4). Note, stronger staining fibers are
more oxidative (slow twitch type I), and light staining fibers aremore glycolytic (fast twitch type II). The data are presented asmeans S.E. Student’s unpaired
t test was used. *, p	 0.05. AUC, area under the curve.
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(i) intracellular signaling; and (j) protein stability, complex
assembly, and post-translation modifications. Therefore, in
silico analysis using a system biology approach (55), highlights
Nln as a (indirect) regulator of several physiological and cel-
lular processes in addition to energy metabolism. Further
biological investigation is necessary to further validate these
in silico data.
DISCUSSION
The major findings presented here are the generation and
phenotype characterization of Nln KO mice. Nln was first
described as a novel neurotensin-cleaving enzyme and received
the first denomination of “neurotensin-degrading neutral met-
alloendopeptidase” (3). Whereas pharmacological studies have
associated Nln to distinct physiological functions and several
pathologies, one can reasonably argue that its actual physiolog-
ical role is still elusive (56). Here, the characterization of Nln
KO mice uncovered the physiological relevance for this oligo-
peptidase in the regulation of energy metabolism. Insulin resis-
tance and diabetes type 2 are for a long time associated with
increased cardiovascular risk factors, including dyslipidemia,
hypertension, impaired fibrinolysis, coagulation, and obesity
(57). Together with cardiovascular diseases, diabetes type 2 is
one of the leading causes of mortality and mobility in the mod-
ern world (35). KO mice were shown here to have increased
glucose tolerance, insulin sensitivity, and liver gluconeogenesis.
Hence, these data suggest a novel therapeutic possibility, which
FIGURE 11.Bloodpressure.A and B, mean arterial pressure (A,MAP) (expressed inmmHg) and heart rate (B, expressed in beats perminute, BPM)measured by
femoral artery catheterization compared KO and WT respectively (n 12). C, effect of bradykinin on MAP after bradykinin injection in femoral vein (5 or 10
mg/kg) (n 7).D, effect of neurotensin onMAP after neurotensin injection in femoral vein (1 nM/mice) (n 8). E, time course of the effect of angiotensin II (Ang
II) onMAP after angiotensin II injection in femoral vein (100 ng/kg) (n 8). The data are presented asmeans S.E. Student’s unpaired t test or ANOVA followed
by Bonferroni’s test shows no different statistical significance between groups.
TABLE 1
Summary of intracellular peptides quantification by LC-ESI-MS
Global analysis of intracellular peptides profile in soleus (predominantly slow twitch
type I fibers), gastrocnemius (predominantly fast twitch type II fibers), liver, and
epididymal adipose tissue quantified by LC-ESI-MS as Nln substrate (ratio
KO/WT  2.0), product (ratio KO/WT  0.5), or neither substrate or product
(ratio KO/WT 0.5 and 2.0). The percentages indicate the amounts of intracel-
lular peptides that are substrates, products, or not cleaved by Nln (n 5).
MS
spectra
>2.0
increased
<0.5
decreased
<0.5 and>2.0
not changed
Gastrocnemius 318 19 (6%) 0 (0%) 299 (94%)
Soleus 112 2 (2%) 8 (7%) 102 (91%)
Liver 189 2 (1%) 22 (12%) 165 (87%)
Adipose 110 15 (14%) 0 (0%) 95 (86%)
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is to inhibit Nln for improving glucose uptake and peripheral
insulin sensitivity.
Glucosemetabolism is vital for health because it is an impor-
tant fuel for physiological functions (58). Insulin is secreted by
pancreatic-cells and regulates themetabolismof glucose after
food intake, increasing glucose uptake by skeletal muscle and
adipose tissue and decreasing hepatic glucose production by
blocking glycogenolysis and gluconeogenesis (59). The most
important effect of insulin is the increase of glucose uptake,
which can be mediated through AKT phosphorylation, which
induces the translocation of GLUT4 to the plasma membrane
(60–62). KO mice have increased glucose tolerance, insulin
sensitivity, and liver gluconeogenesis. Part of these results is
related to an increase in AKT phosphorylation in skeletal mus-
cle and adipose tissues of KO in response to insulin stimulation.
The lack of changes in liver AKT phosphorylation after insulin
administration can be explained by the similar basal glycemia of
KO and WT animals. KO mice exhibit more gluconeogenesis
than WT animals, which is in accordance with the increased
mRNA expression of specific genes that code for enzymes
involved in gluconeogenesis in the liver (63–66). Moreover, in
silico and experimental analyses corroborates that Nln is linked
to energy metabolism and homeostasis regulation.
Accordingly, KO mice show alteration in mRNA expression
of genes typical for slow twitch type I fibers (reduction ofTnni1,
Tnnic1, Tnnt1, andMyh7), urea cycle (increase of CPSM), and
glycolytic pathway (reduction of PGAM1/2) in the gastrocne-
mius but not in the soleus. Moreover, the histological analyses
of SDH and COX in the gastrocnemius suggested a reduced
mitochondrial oxidative activity. Several reports have shown
that the skeletal muscle fiber composition is an important
determinant in metabolism. Moreover, it is well established
that slow twitch type I fibers act in glucose and lipidmetabolism
and endurance training promotes an increase of type I fiber
muscles (67–72). Indeed, theKOmice ran less thanWTmice in
the low intensity running regime until exhaustion. Taken alto-
gether, these results further suggest that Nln is linked to oxida-
tive metabolic capacity.
Several previous reports correlated metabolic improvement
with a lack of peptidase activity, suggesting that peptidemetab-
olism plays an important function in homeostasis regulation
(29, 30, 33). The phenotypic changes observed in the ACE
transgenic mice are not affected by losartan, an antagonist of
the angiotensin II receptor, suggesting that the renin-angioten-
sin systemwas likely not responsible for this phenotype (35). In
contrast, Nln activity is significantly lower in the fat tissue of
mice that possessed three copies of the ACE gene. A possible
explanation for the latter observation is that ACE acts as a
dipeptidyl-carboxypeptidase releasing dipeptides, which have
been shown to specifically inhibit Nln (35). Reduced Nln activ-
ity in the fat tissue of ACE transgenic mice was associated with
TABLE 2
GeneOntology (GO) obtained for the40proteins representedby thepeptides identified in thegastrocnemius, soleus, liver, andadipose tissues,
including the Nln
GO ID p value Biological process description Genes in test set
6941 4,8E-20 Striated muscle contraction ALDOA, PGAM2, TNNI2, SMPX, MYL1, MYG, and TNNT3
6936 4,8E-12 Muscle contraction ALDOA, PGAM2, TNNI2, SMPX, MYL1, MYG, and TNNT3
3012 1E-11 Muscle system process ALDOA, PGAM2, TNNI2, SMPX, MYL1, MYG, and TNNT3
3009 1,1E-08 Skeletal muscle contraction TNNI2, MYG, and TNNT3
50881 1,2E-07 Musculoskeletal movement TNNI2, MYG, and TNNT3
50879 1,2E-07 Multicellular organismal movement TNNI2, MYG, and TNNT3
15671 2,9E-06 Oxygen transport HBB and HBA
46461 9,6E-06 Neutral lipid catabolic process APOA2 and CPSM
44269 9,6E-06 Glycerol ether catabolic process APOA2 and CPSM
46464 9,6E-06 Acylglycerol catabolic process APOA2 and CPSM
15669 1,9E-05 Gas transport HBB and HBA
6110 2,1E-05 Regulation of glycolysis PGAM1 and G3PT
46503 2,1E-05 Glycerolipid catabolic process APOA2 and CPSM
6006 2,1E-05 Glucose metabolic process ALDOA, PGAM2, CPSM, and G3PT
43471 6,8E-05 Regulation of cellular carbohydrate catabolic process PGAM1 and G3PT
43470 6,8E-05 Regulation of carbohydrate catabolic process PGAM1 and G3PT
44275 9,5E-05 Cellular carbohydrate catabolic process ALDOA, PGAM2, and CPSM
19318 9,5E-05 Hexose metabolic process ALDOA, PGAM2, CPSM, and G3PT
FIGURE 12. qPCR for genes obtained after GO analyses. qPCR in either WT
(white bars) or KO (black bars) animals, both 24-week-old (n  4). Several
additional genes identified after GO to be related tomuscle contraction,met-
abolic, and glucose metabolic process analyses were evaluated. Upper panel,
gastrocnemius; lower panel, soleus. The data are represented asmeans S.E.
Student’s unpaired t test was used. *, p	 0.05; **, p	 0.01.
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the distinctive intracellular peptide profile of these ACE trans-
genicmice. These data let us propose that intracellular peptides
could improve insulin sensitivity in the adipose tissue of ACE
transgenicmice (35). Further investigation showed that the lev-
els of specific intracellular peptides are increased in the adipose
tissue of Wistar rats that were fed a high caloric Western diet,
comparedwith rats fed a control diet. Two of these intracellular
peptides (LDBI, GDVNTDRPGLLDL; and DBI, TVGDVNT-
DRPGLLDL) were reintroduced into 3T3-L1 adipocytes
(treated or not with palmitate to induce insulin resistance) and
shown to increase insulin-stimulated glucose uptake (36).
These peptides were also shown to interact with specific pro-
teins only in the adipose tissue from rats fed a high caloric
Western diet (36), therefore suggesting that intracellular pep-
tides could be endogenously involved in insulin-stimulated glu-
cose uptake.
Previous biochemical, structural, and pharmacological evi-
dence supports the high specificity of Nln for degrading small
bioactive peptide substrates (9–11). Here, semiquantitative
mass spectrometry analysis shows that specific intracellular
peptides were affected in the KO compared with theWTmice.
Therefore, it is likely that the phenotypes observed in the KO
should bemediated by the lack ofNln enzymatic activity and, as
a consequence, a shift in the intracellular peptide profile. A
possible molecular mechanism related to intracellular peptide
function includes binding to a protein and, as a consequence,
modification of the ability of this protein to interact with other
proteins. It is important to mention that intracellular peptides,
distinctly from classical biologically active peptides, are sug-
gested to function downstream of plasmamembrane receptors,
regulating signal transduction pathways from inside the cells
(36, 47, 73, 74). Synthetic peptides have been extensively used to
disrupt intracellular protein-protein interactions and alter pro-
tein functions. In some cases, synthetic peptides activate a pro-
tein bymimicking the effect of a protein-protein interaction; in
other cases the peptides inhibit the protein by blocking a pro-
tein-protein interaction. Another possibility includes the bind-
ing of the peptide to a protein followed by alteration of its fold-
ing. Many proteins undergo conformational changes after
binding to a peptide (75). It is possible that endogenous pep-
tides perform similar functions as found for synthetic peptides
(74). Indeed, genetic analysis of Caenorhabditis elegans shows
that under stress of mitochondrial protein misfolding, peptide
signals are emitted from the mitochondrial matrix to the
nucleus, which regulate nuclear-encoded mitochondrial chap-
erone genes (76). Moreover, Thimet oligopeptidase inhibition
using siRNA has been shown to affect -adrenergic signal
transduction in parallel to the intracellular peptide profile (73).
Therefore, it is an exciting possibility to suggest that the phe-
notypes observed here in the KO mice are mediated by intra-
cellular peptides caused by an oligopeptidase (77) action.
Nln have been suggested to participate in several important
physiological processes like cardiovascular and renal homeo-
stasis, pain perception, and regulation of the reproductive axis
and recently also in the brain response to stroke (26, 28,
78–81). Alsomany studies using shRNAor chemical inhibitors
supported the involvement of Nln in these physiological pro-
cesses (24, 28, 78). Even though Nln is expressed widely in the
central nervous system and peripheral organs of mammals (13,
83, 84), its absence, as shown here, is not lethal. KOmice repro-
duce normally and have normal blood pressure and heart rate
when compared with WT mice. It has been previously sug-
gested that in vivoNln contributes to themetabolism of several
endogenous peptides including neurotensin, bradykinin, ang-
iotensins, substance P, opioids (i.e. metorphamide, dynorphin
A1–8), somatostatin, and hemopressin (5, 10, 26, 80). The pres-
ence of Nln activity in vascular endothelial cells suggested a
possible physiological role for Nln in blood pressure control
(79). However, even after neuropeptide injection (bradykinin,
angiotensin II, and neurotensin), KO andWTmice have similar
behaviors in blood pressure alterations. A parallel study con-
ducted in our laboratory suggested that Nln knock-out only
affects the levels of Met-enkephalin and octapeptide and thus
exerts only a minor effect on intracellular peptide metabolism
in the brain (82). Altogether, these data suggest that other pep-
tidasesmay efficiently compensate the lack of Nln in physiolog-
ical neuropeptide metabolism. However, further investigations
are necessary to uncover the enzyme(s) involved in such com-
pensatory mechanisms.
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